# Rafarma Pharmaceuticals, Inc. (RAFA)

> Healthcare · US · Reports in USD

Fundamental indicators from Sponda, adjusted for inflation.

[HTML version](https://sponda.capital/en/RAFA/fundamentals)

## Annual figures

| Year | Revenue (M) | Net Inc. (M) | FCF (M) | Debt (M) | Equity (M) |
| --- | --- | --- | --- | --- | --- |
| 2025 | $ 284.6K | $ 75.8K | $ -1.0K | $ 0 | $ 10.38M |
| 2024 | $ 9.54M | $ 279.6K | $ -714.7K | $ 0 | $ 10.38M |
| 2023 | $ 28.82M | $ 1.02M | $ -20.43M | $ 2.18M | $ 57.21M |
| 2022 | $ 71.85M | $ 5.54M | $ 7.47M | $ 909.0K | $ 77.90M |
| 2021 | $ 92.01M | $ 13.76M | $ -7.19M | $ 1.70M | $ 69.51M |

Columns not available in this view: annualPriceMultiples, dividends. They require live market data and are shown on the HTML page instead.

## Leverage and liquidity

| Indicator | Value |
| --- | --- |
| Gross Debt / Eq | 0.00 |
| Liabilities / Eq | 0.16 |
| Current Ratio | 1.13 |

## Debt coverage

| Indicator | Value |
| --- | --- |
| Gross Debt / Earnings | 0.00 |
| Gross Debt / FCF | 0.00 |

## Other views

- [Metrics](https://sponda.capital/en/RAFA.md)
- [Charts](https://sponda.capital/en/RAFA/charts.md)
- [Compare](https://sponda.capital/en/RAFA/compare.md)
- [Indicator definitions](https://sponda.capital/en/screener.md)

Data as of 2026-08-13.